NREP
NEW REPRESENTATIVE AT IB RECEIVED
08/01/2024
Back to search
Official data from USPTO
BIONORICA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
BIONORICA
ST13
US500000079070126Class
3, 5, 16
Filing
79070126
Registration
3870253
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
73
Latest update
08/01/2024
Trademark type
Word
Nice classes
3, 5, 16
Filing date
03/26/2009
Registration date
11/02/2010
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/15/2020
Last transaction
12/15/2020
Responsible office
United States Patent and Trademark Office
Status code
706
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
Neumarkt, DE
Examiner
LOTT, MAUREEN DALL
Law office
M80
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
B. S. (pessoa física)
B. S. (pessoa física)
Bionorica AG
Representatives
KENNETH F. FLOREK FLOREK & ENDRES PLLC
Technical classification
Nice Classes
Class 3Class 5Class 16
Vienna Codes
No Vienna codes available.
Goods and services
Class 3
Essential oils for use in the manufacture of cosmeticshair lotions and perfumery; hair lotions; dentifrices
Class 5
Pharmaceutical preparations for use in the treatmentcuremitigation or prevention of gingivitishalitosisstomatitisperiodontitisinflammation of the oral cavity and pharyngeal cavityhypersensitivity of teethanginaatherosclerosisbronchial asthmacirculatory disordersconstipationdiarrheaheart failureheart rhythm disordershigh blood pressureindigestioninsomniamigrainemotion sicknessnauseapeptic ulcersvomitingallergygynecological disorders affecting menstruationsterilitymenstrual syndromesdysmenorrhoeainfertilitygenital tract infectionspelvic inflammatory diseasesvaginal discomfort due to menopausal atrophic changesanatomical abnormalities of the headthe extremitieschestabdomen and organsneoplasiabreast neoplasmbreast cancermastopathymastodyniapremenstrual syndromeclimacteric complaintsbreast painblood conditions and disordersblood circulation disordershigh blood pressurehypertensionpulmonary diseasesheart rhythm disordersheart failureurological diseasessexually transmitted diseases and inflammatory pelvic diseasesmenopausal complaints due to therapeutically induced menopausetamoxifen induced hot flushes of breast cancer survivorsclimactic sleep disturbancesdepressive moodsprotection of the skeletal systemosteoporosiscentral nervous system infectionsbrain diseasescentral nervous system movement disordersocular motility disordersspinal cord diseasespsycho vegetative disordersdepressive syndromeanxietynervous unrestperipheral nervous system infectionsperipheral nervous system movement disordersnerve compression syndromesneuritisneuralgia and regional pain syndromesdiseases and disorders of the kidneyurological disorderschronic infections of the bladdercystitispyelonephritisglomerulonephritisinterstitial nephritisnephrolithiasiscancerurolith prophylaxisdizzinessmigrainedepressioninflammations of the upper and lower respiratory organssinusesbronchitistonsillitisarthritisosteoarthritisfevercoughcoldAlzheimer's diseaseinfection of respiratory tractinfection of urinary tracturinary obstructionchronic venous insufficiencyprostate hyperplasiamuscle painssoft tissue rheumatismmusculoskeletal diseaseliver diseasehepatitiscirrhosis of liverperiodontal diseases and dental caries; pharmaceutical preparations for use as an antidepressantdiuretichypnoticsedativeanaleptictranquilizer; haemorrhoidal ointmentlaxativenasal decongestant capsulesnasal spray preparationsnon-narcotic analgesicsthroat lozenges; medicinal preparations in tablet formmenstruation circulation regulating tablets; pharmaceutical preparationsfor hormone regulation and hormone replacement; pharmaceutical preparations for sensory organsfor use in ophthalmologyotolaryngology and dermatology ; pharmaceutical preparations for regulation and strengthening of the immune systempharmaceutical preparations for treating of and providing temporary relief for occasional minor irritationpainsore mouthsore gumssore throatpain associated with canker sorespain due to minor irritation or injury of the mouth and gumspain due to minor dental procedurespain due to minor irritations caused by dentures or orthodontic appliancessore gums due to teething in infants and children four months of age and older; pharmaceutical productsmedicated dentalgum and mouth washesmedicated dentalgum and mouth rinsemedicated toothpastesmedicated oral-care gelsmedicated dental gelsmedicated lozengescough lozengesmedicated chewing gummedicated gels and fluids in the nature of medicated balmsmedicated dental tapesmedicated dental ribbonsmedicated dental polish; pharmaceutical preparations for dental purposesplaque disclosing reagentsperiodontal diagnostic reagents for medical purposes for detecting derivatives from periodontal bacteria and cariesdiagnostic reagents for detecting derivatives from caries-causing bacteria and medicines for the prevention and treatment of periodontal diseasesdental cariescanker sorescold soresmucositis and oral and tongue cancers; medicated mouth spraysplant extracts for veterinary and pharmaceutical purposes; sanitary preparations for medical use; sanitary preparations for hygieneantisepticsoral antisepticsdisinfectants for health purposes; medicated sanitary preparations for the treatmentcleaning and protection of the skin; dietary supplements in the form of tabletsdropscapsulesextract preparationsbalms or in liquid formcontaining plant extracts; dietetic foods adapted for medical use in the form of tabletsdropscapsulesextract preparationsbalms or in liquid form; food for medically restricted dietsfood for diabeticsfood supplements containing plant extractsfood supplements derived from plants or plant extractsall aforesaid goods in the form of tabletsdropscapsulesextract preparationsbalms or in liquid form; vitamin and mineral supplements; food and food supplementsherbal teas for medicinal purposes and medicinal teas; nutritional additives for use in foods and dietary supplements for human consumption; dietetic food supplementsdietary supplementsfood supplements and dietary food supplements; mineral food supplementsfood supplements based on amino acidsminerals and/or trace elementsmedical plasters; materials for dressingsgauze and bandages; all purpose disinfectantsmaterial for stopping teeth; dental wax
Class 16
Paper; cardboard; goods made from paper and cardboardpaper bagscoastersworks of art in the nature of art prints; printed matterbooksmagazinesjournalsnewspapersperiodicalsleafletsmanualscatalogs and brochures in the fields of health and medicine; printed reviews in the nature of a series of written articles in the fields of health and medicine; bookbinding materialbook bindings; photographs; stationery; adhesives for stationery or household purposes; artists' materialsartists' pastelsartists' pencilsartists' penspainting sets for children; paint brushes; typewriters; office requisites except furniturepunchesstaplerserasersdesk padspencil sharpeners; instructional and teaching materialprinted instructional and teaching material in the field of medicine and phytopharmacy; paper bagsenvelopes and pouches for packagingplastic bags and bubble packs for packaging
Publications
History of USPTO decisions and trademark events.
73 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/18/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/03/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
09/09/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
04/22/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/17/2023
INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
09/01/2021
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
08/15/2021
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
12/15/2020
71AG
REGISTERED-SEC.71 ACCEPTED
12/15/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/09/2020
ES71
TEAS SECTION 71 RECEIVED
09/16/2020
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
11/02/2019
RNWL
INTERNATIONAL REGISTRATION RENEWED
04/11/2019
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
01/11/2018
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
12/07/2017
INPC
INVALIDATION PROCESSED
12/07/2017
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
11/29/2017
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
03/29/2017
71.P
REGISTERED - PARTIAL SEC 71 ACCEPTED
03/29/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/28/2017
ES71
TEAS SECTION 71 RECEIVED
10/12/2016
NREP
NEW REPRESENTATIVE AT IB RECEIVED
06/12/2014
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/18/2013
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/11/2011
FIMP
FINAL DISPOSITION PROCESSED
02/11/2011
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/02/2011
R.PR
REGISTERED-PRINCIPAL REGISTER
11/02/2010
CHLD
CHANGE OF OWNER RECEIVED FROM IB
09/02/2010
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/17/2010
PUBO
PUBLISHED FOR OPPOSITION
08/17/2010
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
07/12/2010
ALIE
ASSIGNED TO LIE
07/12/2010
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/09/2010
XAEC
EXAMINER'S AMENDMENT ENTERED
07/09/2010
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/09/2010
GNEA
EXAMINERS AMENDMENT E-MAILED
07/09/2010
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/09/2010
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
06/14/2010
GPRA
PRIORITY ACTION E-MAILED
06/14/2010
CPRA
PRIORITY ACTION WRITTEN
06/14/2010
XAEC
EXAMINER'S AMENDMENT ENTERED
06/07/2010
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/07/2010
GNEA
EXAMINERS AMENDMENT E-MAILED
06/07/2010
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/07/2010
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/29/2010
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/29/2010
ALIE
ASSIGNED TO LIE
05/28/2010
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/12/2010
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/12/2010
NAUD
NOTICE OF UNRESPONSIVE AMENDMENT - MAILED
04/14/2010
NAUD
REPORT UNRESPONSIVE AMENDMENT - COMPLETED
04/13/2010
ACEC
AMENDMENT FROM APPLICANT ENTERED
03/26/2010
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/26/2010
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/24/2010
FAXX
FAX RECEIVED
03/24/2010
FAXX
FAX RECEIVED
03/23/2010
NAUD
NOTICE OF UNRESPONSIVE AMENDMENT - MAILED
02/26/2010
NAUD
REPORT UNRESPONSIVE AMENDMENT - COMPLETED
02/26/2010
ACEC
AMENDMENT FROM APPLICANT ENTERED
02/26/2010
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/26/2010
ALIE
ASSIGNED TO LIE
02/23/2010
PAPER RECEIVED
01/25/2010
RFNT
REFUSAL PROCESSED BY IB
10/03/2009
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/03/2009
RFRR
REFUSAL PROCESSED BY MPU
08/03/2009
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/01/2009
CNRT
NON-FINAL ACTION WRITTEN
07/31/2009
MAFR
APPLICATION FILING RECEIPT MAILED
07/28/2009
DOCK
ASSIGNED TO EXAMINER
07/24/2009
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/24/2009
LIMS
LIMITATION OF GOODS/SERVICES FROM IB ENTERED
07/23/2009
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/23/2009
Continuous trademark protection
Get notified about every new filing that threatens BIONORICA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.